Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Study tests whether blind dry needling actually targets the correct muscles in tennis elbow

NCT ID NCT07042997

First seen Sep 30, 2025 · Last updated Jun 22, 2026 · Updated 41 times

Summary

This study looks at whether blind dry needling (inserting thin needles into muscles without imaging guidance) accurately targets the forearm extensor muscles in people with tennis elbow. Researchers will use ultrasound to see if the needle ends up in the intended muscle. The study involves 40 adults aged 18-70 who have had lateral elbow pain for at least 6 weeks and have active trigger points. The goal is to measure how often the needle hits the correct muscle, not to test if it reduces pain.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LATERAL EPICONDYLITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

dry needling procedure

What this could lead to

If successful, this could help improve dry needling techniques for tennis elbow, making treatments more precise and effective.

What could go wrong

This is a small, early-stage study with only 40 participants. It only checks accuracy, not whether the treatment actually helps pain or recovery.

Conditions

The condition(s) this trial relates to.

epicondylitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.